The Pipeline represents a comprehensive approach to advancing Chronic Disease care and management through cutting-edge research and development. We are actively exploring new therapies, technologies, and preventative measures aimed at improving outcomes for individuals affected by chronic inflammation. From novel medications to state-of-the-art screening tools, our pipeline focuses on innovation and accessibility, ensuring that effective solutions are available to those in need. Together, we can pave the way for a future where Chronic Diseases  are better managed and prevented. 

We developed: 

1. IAP-Biodefense: a platform technology to address individual health care for each unique disease (patent pending)

2. STAP-Test: a predictive test for chronic diseases (Patented)

3. IAP-Quantum: a drug delivery system  (Patent pending)

4. IAP-Discovery: a drug discovery system (Patent pending)